{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:16Z","timestamp":1792790476786,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12132-6","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:49:38Z","timestamp":1765536578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expression and clinical significance of peripheral blood NK cell surface co-signaling molecules in active pulmonary tuberculosis patients"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0715-2958","authenticated-orcid":false,"given":"Jing","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-4536","authenticated-orcid":false,"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-9807","authenticated-orcid":false,"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-780X","authenticated-orcid":false,"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"12132_CR1","volume-title":"Global tuberculosis report 2022[M]","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Global tuberculosis report 2022[M]. Geneva: World Health Organization; 2022."},{"issue":"10181","key":"12132_CR2","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin J, Cox H, Pai M. Tuberculosis[J]. Lancet. 2019;393(10181):1642\u201356.","journal-title":"Lancet"},{"key":"12132_CR3","doi-asserted-by":"crossref","unstructured":"Scriba TJ, Coussens AK, Fletcher HA, Jacobs WR Jr., McShane H, Mizrahi V, et al. Human immunology of tuberculosis[J]. Microbiol Spectr. 2017;5(1):5.1.15.","DOI":"10.1128\/microbiolspec.TBTB2-0016-2016"},{"key":"12132_CR4","doi-asserted-by":"publisher","first-page":"763591","DOI":"10.3389\/fcimb.2021.763591","volume":"11","author":"J Mi","year":"2021","unstructured":"Mi J, Liang Y, Liang J. The research progress in immunotherapy of Tuberculosis[J]. Front Cell Infect Microbiol. 2021;11:763591.","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"12132_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/cmi.2017.88","volume":"14","author":"CH Liu","year":"2017","unstructured":"Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion[J]. Cell Mol Immunol. 2017;14(12):963\u201375.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"12132_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1615\/CritRevImmunol.v26.i6.40","volume":"26","author":"Y Yoshikai","year":"2006","unstructured":"Yoshikai Y. Immunological protection against Mycobacterium tuberculosis Infection[J]. Crit ReviewsTM Immunol. 2006;26(6):515\u201326.","journal-title":"Crit ReviewsTM Immunol"},{"key":"12132_CR7","doi-asserted-by":"crossref","unstructured":"Mayer-Barber KD, Barber DL. Innate and adaptive cellular immune responses to Mycobacterium tuberculosis Infection[J]. Cold Spring Harb Perspect Med. 2015. p. a018424.","DOI":"10.1101\/cshperspect.a018424"},{"key":"12132_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fcimb.2020.00208","volume":"10","author":"V Stary","year":"2020","unstructured":"Stary V, Stary GNK, Cell-Mediated R, Responses. Memory-Like, Adaptive, or Antigen-Specific?[J]. Front Cell Infect Microbiol. 2020;10:208.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"12132_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nri.2015.9","volume":"16","author":"A Cerwenka","year":"2016","unstructured":"Cerwenka A, Lanier LL. Natural killer cell memory in infection, inflammation and cancer[J]. Nat Rev Immunol. 2016;16(2):112\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"7229","key":"12132_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"JC Sun","year":"2009","unstructured":"Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells[J]. Nature. 2009;457(7229):557\u201361.","journal-title":"Nature"},{"key":"12132_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fimmu.2017.00967","volume":"8","author":"JA Chore\u00f1o Parra","year":"2017","unstructured":"Chore\u00f1o Parra JA, Mart\u00ednez Z\u00fa\u00f1iga N, Jim\u00e9nez Zamudio LA. Memory of natural killer cells: A new chance against Mycobacterium tuberculosis?[J]. Front Immunol. 2017;8:967.","journal-title":"Front Immunol"},{"issue":"4","key":"12132_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/mi.2016.105","volume":"10","author":"S Venkatasubramanian","year":"2017","unstructured":"Venkatasubramanian S, Cheekatla S, Paidipally P. IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis[J]. Mucosal Immunol. 2017;10(4):1031\u201342.","journal-title":"Mucosal Immunol"},{"key":"12132_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fcimb.2020.00120","volume":"10","author":"LD Harris","year":"2020","unstructured":"Harris LD, Khayumbi J, Ongalo J. Distinct human NK cell phenotypes and functional responses to Mycobacterium tuberculosis in adults from TB endemic and Non-endemic Regions[J]. Front Cell Infect Microbiol. 2020;10:120.","journal-title":"Front Cell Infect Microbiol"},{"key":"12132_CR14","doi-asserted-by":"publisher","first-page":"127393","DOI":"10.1016\/j.micres.2023.127393","volume":"273","author":"Y Qin","year":"2023","unstructured":"Qin Y, Wang Q, Shi J. Immune checkpoint modulating T cells and NK cells response to Mycobacterium tuberculosis infection[J]. Microbiol Res. 2023;273:127393.","journal-title":"Microbiol Res"},{"key":"12132_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2020.00167","volume":"11","author":"M Khan","year":"2020","unstructured":"Khan M, Arooj S, Wang H. NK Cell-Based immune checkpoint Inhibition[J]. Front Immunol. 2020;11:167.","journal-title":"Front Immunol"},{"issue":"5","key":"12132_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2016.04.022","volume":"44","author":"J Attanasio","year":"2016","unstructured":"Attanasio J, Wherry EJ. Costimulatory and coinhibitory receptor pathways in infectious Disease[J]. Immunity. 2016;44(5):1052\u201368.","journal-title":"Immunity"},{"issue":"12","key":"12132_CR17","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.4049\/jimmunol.1200990","volume":"189","author":"I Sada-Ovalle","year":"2012","unstructured":"Sada-Ovalle I, Ch\u00e1vez-Gal\u00e1n L, Torre-Bouscoulet L. The Tim3\u2013Galectin 9 pathway induces antibacterial activity in human macrophages infected with Mycobacterium tuberculosis[J]. J Immunol. 2012;189(12):5896\u2013902.","journal-title":"J Immunol"},{"issue":"2","key":"12132_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.cyto.2015.05.012","volume":"76","author":"F Wang","year":"2015","unstructured":"Wang F, Hou H, Wu S. Tim-3 pathway affects NK cell impairment in patients with active tuberculosis[J]. Cytokine. 2015;76(2):270\u20139.","journal-title":"Cytokine"},{"issue":"10","key":"12132_CR19","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/eji.201545480","volume":"45","author":"F Wang","year":"2015","unstructured":"Wang F, Hou H, Wu S. TIGIT expression levels on human NK cells correlate with functional heterogeneity among healthy individuals[J]. Eur J Immunol. 2015;45(10):2886\u201397.","journal-title":"Eur J Immunol"},{"issue":"9","key":"12132_CR20","first-page":"641","volume":"83","author":"H Ariga","year":"2008","unstructured":"Ariga H, Harada N. [Evolution of IGRA researches][J]. Kekkaku: [Tuberculosis]. 2008;83(9):641\u201352.","journal-title":"Kekkaku: [Tuberculosis]"},{"issue":"5","key":"12132_CR21","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/cid\/ciab144","volume":"73","author":"MP Acharya","year":"2021","unstructured":"Acharya MP, Pradeep SP, Murthy VS. CD38\u2009+\u2009CD27\u2013TNF-\u03b1\u2009+\u2009on Mtb -specific CD4\u2009+\u2009T cells is a robust biomarker for tuberculosis Diagnosis[J]. Clin Infect Dis. 2021;73(5):793\u2013801.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"12132_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2020.03.064","volume":"81","author":"O Est\u00e9vez","year":"2020","unstructured":"Est\u00e9vez O, Anibarro L, Garet E. Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection[J]. J Infect. 2020;81(1):57\u201371.","journal-title":"J Infect"},{"issue":"10","key":"12132_CR23","first-page":"918","volume":"38","author":"B Yang","year":"2022","unstructured":"Yang B, Zhai F, An H. [Expression of CD160 in natural killer (NK) cells from patients with active tuberculosis and its relationship with cell functions][J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi\u2009=\u2009Chinese. J Cell Mol Immunol. 2022;38(10):918\u201324.","journal-title":"J Cell Mol Immunol"},{"key":"12132_CR24","doi-asserted-by":"publisher","first-page":"113694","DOI":"10.1016\/j.ejmech.2021.113694","volume":"224","author":"M Piotrowska","year":"2021","unstructured":"Piotrowska M, Spodzieja M, Kuncewicz K. CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions[J]. Eur J Med Chem. 2021;224:113694.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"12132_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","volume":"10","author":"Y Fu","year":"2020","unstructured":"Fu Y, Lin Q, Zhang Z. Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity[J]. Acta Pharm Sinica B. 2020;10(3):414\u201333.","journal-title":"Acta Pharm Sinica B"},{"issue":"6","key":"12132_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/infdis\/jir868","volume":"205","author":"RJ Snelgrove","year":"2012","unstructured":"Snelgrove RJ, Cornere MM, Edwards L. OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis Infection[J]. J Infect Dis. 2012;205(6):975\u201383.","journal-title":"J Infect Dis"},{"issue":"1","key":"12132_CR27","doi-asserted-by":"publisher","first-page":"8423","DOI":"10.1038\/s41467-023-44152-8","volume":"14","author":"AR Gress","year":"2023","unstructured":"Gress AR, Ronayne CE, Thiede JM. Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapy[J]. Nat Commun. 2023;14(1):8423.","journal-title":"Nat Commun"},{"issue":"4","key":"12132_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1053\/j.seminoncol.2015.05.014","volume":"42","author":"MF Sanmamed","year":"2015","unstructured":"Sanmamed MF, Pastor F, Rodriguez A. Agonists of Co-stimulation in cancer immunotherapy directed against CD137, OX40, GITR, CD27, CD28, and ICOS[J]. Semin Oncol. 2015;42(4):640\u201355.","journal-title":"Semin Oncol"},{"issue":"3","key":"12132_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10930-020-09896-y","volume":"39","author":"JC Barragan-Galvez","year":"2020","unstructured":"Barragan-Galvez JC, Gonzalez-Orozco M, Hernandez-Flores A. Prokaryotic expression of the immunoglobulin\u2019s domains of CRTAM to characterize a monoclonal Antibody[J]. Protein J. 2020;39(3):224\u201331.","journal-title":"Protein J"},{"issue":"9","key":"12132_CR30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/intimm\/dxh299","volume":"17","author":"N Arase","year":"2005","unstructured":"Arase N, Takeuchi A, Unno M. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8\u2009+\u2009T cells[J]. Int Immunol. 2005;17(9):1227\u201337.","journal-title":"Int Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:49:41Z","timestamp":1765536581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12132"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12132-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed on human participants were in accordance with the ethical standards of the Helsinki Declaration and ethically approved by the Ethics Committee of Beijing Chest Hospital, Capital Medical University (Ethics approval number: YJS-2023-03). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants in this study provided their consent and signed an informed consent form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1715"}}